Ana-Maria Orbai

Assistant Professor, Director Psoriatic Arthritis Program

Johns Hopkins University School of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Ana-Maria Orbai is an Assistant Professor and the Director of the Psoriatic Arthritis Program at Johns Hopkins University School of Medicine, located in the United States. Her research focuses on psoriatic arthritis and includes topics such as composite outcome measures, treatment responses, and the long-term safety of various therapies. She has published recent articles on treatment for severe cutaneous lupus erythematosus and the characteristics of patient-reported treatment success in psoriatic arthritis, contributing significantly to the field.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (9)

Danielle Robinson

University of Oxford

UNITED KINGDOM

View details

Lihi Eder

CANADA

View details

Ying Ying Leung

Associate professor

Duke-NUS Medical School

SINGAPORE

View details

William Tillett

University of Bath

UNITED KINGDOM

View details

Philip Helliwell

Professor of Clinical Rheumatology

University of Leeds

UNITED KINGDOM

View details

Laura Prichett

Assistant Professor

Johns Hopkins University School of Medicine

UNITED STATES

View details

vibeke strand

Adjunct Clinical Professor

Stanford University School of Medicine

UNITED STATES

View details

Erika Darrah

Johns Hopkins University

UNITED STATES

View details

Laura Coates

University of Oxford

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ana-Maria Orbai

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Intravenous immunoglobulin as a treatment for severe, refractory cutaneous lupus erythematosus requiring hospitalization: Three cases and review of the literature

Composite Outcome Measures for Psoriatic Arthritis: Project Updates 2024

Composite Outcome Measures for Psoriatic Arthritis: Project Updates 2024

Variability of Psoriatic Arthritis Impact of Disease questionnaire (PsAID12) thresholds in psoriatic arthritis: data from the ReFlaP study

Long-term safety of bimekizumab in adult patients with axial spondyloarthritis or psoriatic arthritis: pooled results from integrated phase IIb/III clinical studies

Anti-PCNA antibodies in psoriatic arthritis: a case–control study

Characteristics associated with patient-reported treatment success in psoriatic arthritis

Association Between Patient Perception of Disease Status and Different Components of the Minimal Disease Activity Criteria in Psoriatic Arthritis

Composite Outcome Measures for Psoriatic Arthritis: OMERACT and 3 and 4 Visual Analog Scale Progress in 2023

SOX‐5 Transcription Factor: a Novel Psoriatic Autoantigen Preferentially Found in Women

Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working Group

Association between obesity and likelihood of remission or low disease activity status in psoriatic arthritis applying index-based and patient-based definitions of remission: a cross-sectional study

Efficacy of Guselkumab in Treating Nails, Scalp, Hands, and Feet in Patients with Psoriasis and Self-reported Psoriatic Arthritis

Impact of Physician-Defined Flares on Quality of Life and Work Impairment: An International Survey of 2238 Patients With Psoriatic Arthritis

Meaningful Improvement in General Health Outcomes with Guselkumab Treatment for Psoriatic Arthritis: Patient-Reported Outcomes Measurement Information System-29 Results from a Phase 3 Study

Secukinumab in United States Biologic-Naïve Patients With Psoriatic Arthritis: Results From the Randomized, Placebo-Controlled CHOICE Study

Identifying Minimal and Meaningful Change in a Patient‐Reported Outcomes Measurement Information System for Rheumatoid Arthritis: Use of Multiple Methods and Perspectives

What influences patients' opinion of remission and low disease activity in psoriatic arthritis? Principal component analysis of an international study of 424 patients.

Work absenteeism and disability associated with psoriasis and psoriatic arthritis in the USA—a retrospective study of claims data from 2009 TO 2020

Ixekizumab for Psoriatic Arthritis: Safety, Efficacy, and Patient Selection

Collaborators (9)

Danielle Robinson

Lihi Eder

Ying Ying Leung

William Tillett

Philip Helliwell

Laura Prichett

vibeke strand

Erika Darrah

Laura Coates

Make your next move.